10 Best Stocks To Buy For Financial Stability

Page 7 of 10

4. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 81 

Johnson & Johnson (NYSE:JNJ) researches and develops, manufactures, and sells various products in the healthcare field. In the fourth quarter of 2024, the company reported sales growth of 5.3% to $22.5 billion, with operational growth of 6.7% and adjusted operational growth of 5.7%. In February, the company announced that the European Medicines Agency has recommended expanding the approval of a new under-the-skin version of RYBREVANT. This treatment can be used with LAZCLUZE as a first-line option for adults with advanced non-small cell lung cancer (NSCLC) that have specific EGFR mutations (exon 19 deletions or exon 21 L858R substitutions). It’s also recommended as a standalone treatment for adults with advanced NSCLC who have EGFR exon 20 insertion mutations and didn’t respond to previous platinum-based chemotherapy.

Page 7 of 10